146
Participants
Start Date
February 23, 2018
Primary Completion Date
July 20, 2023
Study Completion Date
July 20, 2023
BI 754091
Solution for infusion
BI 754111
Solution for infusion
Chang Gung Memorial Hospital(Linkou), Taoyuan District
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
NCKUH, Tainan City
National Cancer Center Hospital East, Chiba, Kashiwa
Kanagawa Cancer Center, Kanagawa, Yokohama
Saitama Cancer Center, Saitama, Kitaadachi-gun
Shizuoka Cancer Center, Shizuoka, Sunto-gun
National Cancer Center Hospital, Tokyo, Chuo-ku
Japanese Foundation for Cancer Research, Tokyo, Koto-ku
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Boehringer Ingelheim
INDUSTRY